AACR logo

More articles from Cancer Therapeutics Insights

Combined Targeting of mTOR and AKT Is an Effective Strategy for Basal-like Breast Cancer in Patient-Derived Xenograft Models
Siguang Xu, Shunqiang Li, Zhanfang Guo, Jingqin Luo, Matthew J. Ellis, Cynthia X. Ma

Molecular Cancer Therapeutics Aug 2013, 12 (8) 1665-1675; DOI: 10.1158/1535-7163.MCT-13-0159
Mechanism of Differentiation-Enhanced Photodynamic Therapy for Cancer: Upregulation of Coproporphyrinogen Oxidase by C/EBP Transcription Factors
Sanjay Anand, Tayyaba Hasan, Edward V. Maytin

Molecular Cancer Therapeutics Aug 2013, 12 (8) 1638-1650; DOI: 10.1158/1535-7163.MCT-13-0047
Src Mediates Cigarette Smoke–Induced Resistance to Tyrosine Kinase Inhibitors in NSCLC Cells
Simone Filosto, David S. Baston, Samuel Chung, Cathleen R. Becker, Tzipora Goldkorn

Molecular Cancer Therapeutics Aug 2013, 12 (8) 1579-1590; DOI: 10.1158/1535-7163.MCT-12-1029
Expression of Leukemia-Associated Fusion Proteins Increases Sensitivity to Histone Deacetylase Inhibitor–Induced DNA Damage and Apoptosis
Luca A. Petruccelli, Filippa Pettersson, Sonia V. del Rincón, Cynthia Guilbert, Jonathan D. Licht, Wilson H. Miller

Molecular Cancer Therapeutics Aug 2013, 12 (8) 1591-1604; DOI: 10.1158/1535-7163.MCT-12-1039
Antitumor Impact of p14^ARF on Gefitinib-Resistant Non–Small Cell Lung Cancers
Ken Saito, Nagio Takigawa, Naoko Ohtani, Hidekazu Iioka, Yuki Tomita, Ryuzo Ueda, Junya Fukuoka, Kazuhiko Kuwahara, Eiki Ichihara, Katsuyuki Kiura, Eisaku Kondo

Molecular Cancer Therapeutics Aug 2013, 12 (8) 1616-1628; DOI: 10.1158/1535-7163.MCT-12-1239
Preclinical Evaluation of Transcriptional Targeting Strategy for Human Hepatocellular Carcinoma in an Orthotopic Xenograft Mouse Model
Kian Chuan Sia, Hung Huynh, Alexander Yaw Fui Chung, London Lucien Peng Jin Ooi, Kiat Hon Lim, Kam Man Hui, Paula Yeng Po Lam

Molecular Cancer Therapeutics Aug 2013, 12 (8) 1651-1664; DOI: 10.1158/1535-7163.MCT-13-0056
Comparing Histone Deacetylase Inhibitor Responses in Genetically Engineered Mouse Lung Cancer Models and a Window of Opportunity Trial in Patients with Lung Cancer
Tian Ma, Fabrizio Galimberti, Cherie P. Erkmen, Vincent Memoli, Fadzai Chinyengetere, Lorenzo Sempere, Jan H. Beumer, Bean N. Anyang, William Nugent, David Johnstone, Gregory J. Tsongalis, Jonathan M. Kurie, Hua Li, James DiRenzo, Yongli Guo, Sarah J. Freemantle, Konstantin H. Dragnev, Ethan Dmitrovsky

Molecular Cancer Therapeutics Aug 2013, 12 (8) 1545-1555; DOI: 10.1158/1535-7163.MCT-12-0933
Alternative Cytotoxic Effects of the Postulated IGF-IR Inhibitor Picropodophyllin In Vitro
Xuping Wu, Linda Sooman, Malin Wickström, Mårten Fryknäs, Christine Dyrager, Johan Lennartsson, Joachim Gullbo

Molecular Cancer Therapeutics Aug 2013, 12 (8) 1526-1536; DOI: 10.1158/1535-7163.MCT-13-0091
Modulation of OATP1B-Type Transporter Function Alters Cellular Uptake and Disposition of Platinum Chemotherapeutics
Cynthia S. Lancaster, Jason A. Sprowl, Aisha L. Walker, Shuiying Hu, Alice A. Gibson, Alex Sparreboom

Molecular Cancer Therapeutics Aug 2013, 12 (8) 1537-1544; DOI: 10.1158/1535-7163.MCT-12-0926
Vinblastine Rapidly Induces NOXA and Acutely Sensitizes Primary Chronic Lymphocytic Leukemia Cells to ABT-737
Darcy J.P. Bates, Alexey V. Danilov, Christopher H. Lowrey, Alan Eastman

Molecular Cancer Therapeutics Aug 2013, 12 (8) 1504-1514; DOI: 10.1158/1535-7163.MCT-12-1197

Main menu

User menu

Search

More articles from Cancer Therapeutics Insights

Pages

Articles

Info for

About MCT